Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HighCycle Study: Effect of Acetazolamide on Plasma Volume During Acute Exposure to High Altitude in Women and Men

NCT07118462 is registered in ClinicalTrials.gov with Centre d'Expertise sur l'Altitude EXALT as lead sponsor.

NCT NCT07118462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07118462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HighCycle Study: Effect of Acetazolamide on Plasma Volume During Acute Exposure to High Altitude in Women and Men
Lead sponsor
Centre d'Expertise sur l'Altitude EXALT
Phase
Phase 4
Overall status
Recruiting
Start date
July 15, 2024
Completion date
December 31, 2025
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mountain sickness (ams), high altitude effects, high altitude hypoxia, plasma volume, women